Daniel Cohen, MD
Clinical Neurophysiology · Bay Shore, NYNPI 1225080096
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 37 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 66.3% of it on its own, with 4 other manufacturers making up the rest. That places this record below the midpoint for clinical neurophysiology clinicians in NY, where the typical reported total is $1,360.
Across 37 payments — averaging $19.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$479
- Medtronic$81
- Globus Medical$77
- Genentech USA, Inc.$71
- Medexus Pharma, Inc.$15
What the payments were for
- Food & beverage$722100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 30 | $479 |
| Medtronic | 1 | $81 |
| Globus Medical | 1 | $77 |
| Genentech USA, Inc. | 4 | $71 |
| Medexus Pharma, Inc. | 1 | $15 |
How this compares
$722 in reported general payments places this provider in the 35th percentile of 35 clinical neurophysiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Avonex (4 Pack)Interferon Beta-1a | 29 | $310,884 |
| VumerityDiroximel Fumarate | 21 | $187,586 |
| TecfideraDimethyl Fumarate | 14 | $130,927 |
| Nurtec OdtRimegepant Sulfate | 19 | $22,129 |
| Aimovig AutoinjectorErenumab-Aooe | 18 | $17,400 |
| Memantine Hcl | 238 | $7,603 |
| DilantinPhenytoin Sodium Extended | 22 | $7,509 |
| Lacosamide | 64 | $7,209 |
| Donepezil Hcl | 521 | $5,295 |
| Nortriptyline Hcl | 34 | $4,972 |
| Gabapentin | 202 | $4,344 |
| Levetiracetam | 144 | $4,045 |
| Zolmitriptan | 14 | $3,980 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 135 | $2,370 |
| Oxcarbazepine | 42 | $1,892 |
Paid to pharmacies, not to this prescriber.
Other clinical neurophysiology in Bay Shore
- Alcibiades RodriguezNew York$714K
- Farhad Kadkhodaei ElyaderaniBronx$156K
- Jessica Robinson-PappNew York$28K
- Mohini GurmeWest Nyack$13K
- Cecily AntoHauppauge$11K
- Itzhak HaimovicGreat Neck$7K
- Madeline FieldsNew York$5K
- Agnieszka KokoszkaNew York$5K
- Justin SilversteinHauppauge$3K
- Simona ProteasaGreat Neck$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.